Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Myc and YAP roles in the control of the cell cycle [MEF RNA-seq pharmacological treatment]

ABSTRACT: Myc and YAP roles in the control of the cell cycle [MEF RNA-seq pharmacological treatment]

PROVIDER: PRJNA420726 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Myc and YAP roles in the control of the cell cycle [3T9 RNA-seq pharmacological treatment]

Project description:RNAseq analysis of YAP and Myc induced in quiescent and confluent 3T9 fibroblasts treated with Y27632 and Verteporfin

2017-11-22 | GSE83868 | GEO

Myc and YAP roles in the control of the cell cycle [MEF RNA-seq pharmacological treatment]

Project description:Expression profiling by RNA-seq

2017-12-01 | GSE107583 | GEO

Myc and YAP roles in the control of the cell cycle

Project description:Myc and YAP roles in the control of the cell cycle

| PRJNA327238 | ENA

Myc and YAP roles in the control of the cell cycle [3T9 RNA-seq]

Project description:RNAseq analysis of YAP and Myc induced in quiescent and confluent 3T9 fibroblasts

2017-11-22 | GSE83867 | GEO

Myc and YAP roles in the control of the cell cycle [3T9 ChIP-seq]

Project description:ChIPseq analysis of YAP and Myc induced in quiescent and confluent 3T9 fibroblasts

2017-11-22 | GSE83866 | GEO

Myc and YAP roles in the control of the cell cycle [Liver ChIP-seq]

Project description:ChIPseq analysis was performed on liver of tet-YAP and tet-Myc transgenic mice induced for 2 days (R26-mice)

2017-11-22 | GSE83863 | GEO

Myc and YAP roles in the control of the cell cycle [Liver RNA-seq]

Project description:RNAseq analysis was performed on liver of tet-YAP and tet-Myc transgenic mice induced for 2 days (R26-mice) or 4 weeks (laptTA-mice) or in liver tumor noduli.

2017-11-22 | GSE83865 | GEO

Pharmacological YAP activation promotes regenerative repair of cutaneous wounds.

Project description:Chronic cutaneous wounds remain a persistent unmet medical need that decrease expectancy and quality of life. Here, we report that topical application of PY-60, a small molecule activator of the transcriptional coactivator YAP, promotes regenerative repair of cutaneous wounds in pig and human models. Pharmacological YAP activation enacts a reversible pro-proliferative transcriptional program in keratinocytes and dermal cells that results in accelerated re-epithelization and regranulation of the wound bed. These results demonstrate that transient topical administration of a YAP activating agent may represent a generalizable therapeutic approach to treating chronic wounds.

2023-06-11 | GSE234332 | GEO

Tumor metastasis to lymph node requires YAP-dependent metabolic adaptation

Project description:In cancer patients, metastasis of tumors to sentinel lymph nodes (LN) predicts disease progression and often guides treatment decisions. The mechanisms underlying tumor LN metastasis are poorly understood. Using comparative transcriptomics and metabolomics analyses of primary and LN metastatic tumors in mice, we found that LN metastasis requires that tumor cells undergo a metabolic shift toward fatty acid oxidation (FAO). Transcriptional co-activator yes-associated protein (YAP) is selectively activated in LN metastatic tumors, leading to upregulation of genes in the FAO signaling pathway. Pharmacological inhibition of FAO or genetic ablation of YAP suppressed LN metastasis in mice. Several bioactive bile acids were highly accumulated in the LN metastatic tumor. Inhibition of FAO or YAP may merit exploration as therapeutic strategies for mitigating tumor LN metastasis.

2019-02-09 | E-MTAB-7621 | biostudies-arrayexpress

Myc and YAP roles in the control of the cell cycle

Project description:This SuperSeries is composed of the SubSeries listed below.

2017-11-22 | GSE83869 | GEO